Drugs / Pranlukast
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT01539304 | Sep 2010 → Aug 2011 | perennial allergic rhinitis | SamA Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00410735 | Dec 2006 → Jun 2008 | chronic rhinosinusitis | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00127647 Comparator | Nov 2004 → Apr 2005 | seasonal allergic rhinitis | Organon and Co | Completed | Met primary |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pranlukast | “Pranlukast 10% dry syrup, b.i.d.” NCT01539304 ↗ |
| Known as | Azlaire | ChEMBL registry synonym — accepted as the source's own label CHEMBL21333 ↗ |
| Known as | CCN 00401 | ChEMBL registry synonym — accepted as the source's own label CHEMBL21333 ↗ |
| Known as | ONO 1078 | ChEMBL registry synonym — accepted as the source's own label CHEMBL21333 ↗ |
| Known as | Onon | ChEMBL registry synonym — accepted as the source's own label CHEMBL21333 ↗ |
| Known as | RS 411 | ChEMBL registry synonym — accepted as the source's own label CHEMBL21333 ↗ |
| Known as | SB 205312 | ChEMBL registry synonym — accepted as the source's own label CHEMBL21333 ↗ |
| Action | Inhibit | “Cysteinyl leukotriene receptor 1 antagonist” CHEMBL21333 ↗ |
| Modality | Small molecule | — CHEMBL21333 ↗ |
| Route | Oral | “Montelukast 5mg, 10mg or pranlukast 450mg and the corresponding placebo were orally administered to patients with seasonal allergic rhinitis three times a day for 2 weeks.” PMID 18946234 ↗ Nov 2008 |
| Target | CYSLTR1 | “Cysteinyl leukotriene receptor 1 antagonist” CHEMBL21333 ↗ |